| 01/12/2023 |
EU funding: Cohort Network To be Activated Globally In Outbreaks |
| 28/06/2023 |
EU funding: Deciphering stem cell immunity |
| 01/07/2023 |
EU funding: Exploring microbial community stability across mutational spectra |
| 30/06/2023 |
EU funding: Intestinal Gluconeogenesis: Emerging Regulator of Energy Homeostasis |
| 01/07/2023 |
EU funding (€1,100,000): Species-specific aspects in eukaryotic mRNA translation modulation and their implications in diseases |
| 01/11/2023 |
EU funding (€1,218,550): Designing a European Brain Health Landscape |
| 18/09/2023 |
EU funding (€1,444,400): Electro-conductive polymeric 3D scaffolds as novel strategies for biomedical applications |
| 24/11/2023 |
EU funding (€1,483,739): Cross-species Regulation of Action by Controllability: a Keystone of 5-HT signalling? |
| 17/11/2023 |
EU funding (€1,490,250): Scalable Microbial Metabolite Discovery Through Synthetic Biology |
| 24/02/2023 |
EU funding (€1,496,524): A leaky evidence accumulation process (LEAP) for consciousness |
| 08/11/2023 |
EU funding (€1,498,077): INTERnational Cooperation of high containment research infrastructures: from Epidemic Preparedness TO Response |
| 01/05/2023 |
EU funding (€1,498,420): Illuminating the role of selfish genetic elements in somatic tissue homeostasis and aging |
| 18/12/2023 |
EU funding (€1,499,686): Sleeping While Awake: Sleep intrusions during wakefulness and their cognitive consequences |
| 30/06/2023 |
EU funding (€1,531,800): The role of the non-canonical death receptor signalling in cancer and immune cells |
| 03/02/2023 |
EU funding (€1,652,950): Cognition and Neurocomputations of motivation and planning |
| 01/06/2023 |
EU funding (€1,666,776): HOst-Transposon Interactions in the MAle GErmline |
| 18/02/2023 |
EU funding (€1,942,158): Breaching the protective cancer stroma with radiotherapy-responsive liposomes |
| 19/09/2023 |
EU funding (€1,948,125): Nanoscintillators to potentiate brain cancer radiotherapy: from physics to preclinical trials |
| 28/06/2023 |
EU funding (€1,994,500): Elucidating the Spatial and Temporal Dynamics of Acute Myeloid Leukemia Progression Using Functional Omics and High-Throughput In Vivo Screening |
| 13/07/2023 |
EU funding (€1,995,218): Harnessing the cognitive and neurophysiological processes characterising the sleep onset period |
| 01/05/2023 |
EU funding (€10.1M): Fighting childhood obesity to stay healthy all over the life |
| 01/12/2023 |
EU funding (€10.6M): ORTHOpaedic treatment with ALLOgenic combined ATMP in long bone fracture delayed UNION and non-union (ORTHO-ALLO-UNION). |
| 01/04/2023 |
EU funding (€10.8M): Impact of cell shapes on cell behaviour and fate |
| 01/05/2023 |
EU funding (€11.3M): Uncovering the molecular effects of the tubulin code and their impact on organism-wide functions |
| 01/01/2023 |
EU funding (€12M): Understanding Gene ENvironment Interaction in ALcohol-related hepatocellular carcinoma |
| 01/02/2023 |
EU funding (€150,000): A completely biological and human tissue-engineered mesh produced from Cell-Assembled extracellular Matrix (CAM) in vitro for the treatment of Pelvic Organ Prolapse (POP) |
| 25/07/2023 |
EU funding (€150,000): Antagonizing GnRH signaling as a “holistic” therapeutic strategy for Polycystic Ovary Syndrome |
| 27/07/2023 |
EU funding (€150,000): Novel targeted Intervention to Treat Anemia |
| 13/10/2023 |
EU funding (€150,000): Preclinical in vivo validation of a glioblastoma neuro snooper electrical device |
| 01/07/2023 |
EU funding (€150,000): Senolytics repurposing in childhood refractory epilepsies |
| 01/06/2023 |
EU funding (€150,000): Therapeutic discovery for Inflammatory Bowel Disease |
| 01/04/2023 |
EU funding (€150,000): Tuneable Conditional Control of Engineered Bacterial Therapeutics |
| 19/09/2023 |
EU funding (€150,000): Unlocking cognition by Pulsatile GnRH in Alzheimer's DiseasE |
| 24/07/2023 |
EU funding (€195,915): Cerebellar ataxia spatiotemporal transcriptomics atlas |
| 28/06/2023 |
EU funding (€195,915): Characterizing the chromatin landscape of Spinal Muscular Atrophy in response to AAV9 mediated gene therapy |
| 01/06/2023 |
EU funding (€195,915): Glial-neuron crosstalk in the regulation of neurofilament dynamics |
| 18/12/2023 |
EU funding (€195,915): Investigating neuro-immune crosstalk during enteric parasitic infections using human intestinal organoids |
| 01/10/2023 |
EU funding (€2,000,000): Mechanisms of dormancy, activation and sexual conversion in pre-erythrocytic malaria parasites |
| 01/06/2023 |
EU funding (€2,000,000): Role of tissue-resident FOLR2+ Macrophages as Organizers of the Tumor Immune MicroEnvironment |
| 29/06/2023 |
EU funding (€2,049,049): Outlining the Role of IgA in Memory Instruction |
| 28/06/2023 |
EU funding (€2,398,219): A Comprehensive Translational Research and Training Pipeline Harnessing Lipid Metabolism to Improve Prostate Cancer Management and Educate Young Researchers in Tackling Complex Disease |
| 24/07/2023 |
EU funding (€2,475,808): Investigating Virus-Host Interplay in Human Primary Models of Genetically Modified Respiratory Epithelium |
| 08/09/2023 |
EU funding (€2,477,250): Destabilizing vascular colonization to stop meningitis |
| 01/05/2023 |
EU funding (€2,533,255): FUnctional Nucleic Acids as Versatile SMart BUilding BLocks in Non-ConventIonal SolvenTs |
| 11/07/2023 |
EU funding (€2,615,796): The GEne Therapy INnovation Training Network |
| 11/07/2023 |
EU funding (€2,626,200): European Training Program to Understand, Diagnose and Treat Autosomal Dominant Retinal Diseases |
| 14/07/2023 |
EU funding (€2,626,812): Systematic study of IgG4-autoimmune diseases to develop new treatment strategies |
| 21/11/2023 |
EU funding (€2,689,603): A training network for the design of synthetic carbohydrate-based vaccines in the fight against multi-drug resistant nosocomial pathogen Acinetobacter baumannii |
| 24/07/2023 |
EU funding (€2,716,898): Ion Mobility Mass Spectrometry Training Network |
| 11/07/2023 |
EU funding (€2,717,755): Preventing Therapy Resistance in Esophageal Cancer Using Advanced Models and Molecular Signatures |
| 24/07/2023 |
EU funding (€2,748,233): Molecular Dynamic of Neurons during C. elegans Lifespan |
| 01/11/2023 |
EU funding (€2,965,385): Universal GPCR Activity Sensor for Next Generation Drug Discovery |
| 01/12/2023 |
EU funding (€2,999,958): INTERNATIONAL HUMAN EXPOSOME NETWORK PROJECT |
| 25/07/2023 |
EU funding (€211,755): Identification of novel targets to improve glioblastoma therapy |
| 01/12/2023 |
EU funding (€3,000,000): COordination MEchanism for Cohorts and Trials |
| 07/03/2023 |
EU funding (€3,126,348): REAL TIME MOLECULAR IMAGER WITH UNSURPASSED RESOLUTION |
| 01/02/2023 |
EU funding (€3,554,156): Preterm Brain-Oxygenation and Metabolic EU-Sensing: Feed the Brain |
| 01/04/2023 |
EU funding (€3,584,657): Low and very-low-field 3D magnetic resonance spirometry for advanced regional exploration of respiratory diseases |
| 01/06/2023 |
EU funding (€3,826,044): Optimising a High Efficacy Plasmodium vivax Malaria Vaccine |
| 07/03/2023 |
EU funding (€3,959,507): Intelligent design of adenovirus vectors (iAds) |
| 01/07/2023 |
EU funding (€3,995,300): Implementation of an upgraded strategy to reach zero HIV transmission by breastfeeding in rural and urban settings in Zambia – the PROMISE-ZERO study |
| 03/11/2023 |
EU funding (€377,581): Control of Host Mechanics by a Bacterial Pathogen and Functional Impact |
| 28/06/2023 |
EU funding (€4,578,882): Speckle Technology and Digital Biomarkers of Microvascular Function for Monitoring Cardiovascular Diseases |
| 03/11/2023 |
EU funding (€4,887,932): European Viral Outbreak Response Alliance |
| 30/06/2023 |
EU funding (€4,892,256): NaV1.5 regulation fine-tuning as a therapy for cardiac Conduction and Arrhythmic diseases at Risk of suddEn Death |
| 03/11/2023 |
EU funding (€4,999,201): TITAN: Trusted envIronments for confidenTiAl computiNg and secure data sharing |
| 03/02/2023 |
EU funding (€421,269): Menstrual blood multiomics analysis to better diagnose, understand and treat endometriosis |
| 03/11/2023 |
EU funding (€5,000,000): Secure Interactive Environments for SensiTive data Analytics |
| 01/06/2023 |
EU funding (€5,605,576): Preclinical development of a 3rd-generation interleukin-2 targeted to inflammatory sites |
| 01/12/2023 |
EU funding (€5,772,466): Limiting West Nile Virus impact by novel vaccines and therapeutics approaches |
| 01/11/2023 |
EU funding (€6,320,857): Liver Electronic Offering Platform with Artificial intelligence-based Devices |
| 01/05/2023 |
EU funding (€6,383,217): Gut Microbiota-Induced Tregs for Inflammatory-Bowel-Disease (IBD) Immunotherapy (MITI2) |
| 01/06/2023 |
EU funding (€6,553,472): Next-generation models and genetic therapies for rare neuromuscular diseases |
| 01/11/2023 |
EU funding (€6,952,110): Drug REpurposing with Artificial intelligence for Muscular disorderS |
| 01/07/2023 |
EU funding (€6,998,038): Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe) |
| 01/04/2023 |
EU funding (€6,998,199): e-Intervention Enhancing Mental Health in Adolescents |
| 01/05/2023 |
EU funding (€7,369,449): INNOVATIVE NASAL VACCINES TO PREVENT PATHOGEN COLONIZATION AND INFECTION IN THE UPPER RESPIRATORY TRACT |
| 28/06/2023 |
EU funding (€7,425,447): Therapies for Renal Ciliopathies |
| 01/05/2023 |
EU funding (€7,999,852): Novel advanced and repurposed therapeutics for vision restoration in a group of severe rare ocular surface diseases: from validation to first clinical investigations |
| 01/07/2023 |
EU funding (€8,000,000): The Integrate study : An adaptive platform trial for the development of a new intervention to combat Lassa fever in Africa |
| 01/10/2023 |
EU funding (€9,600,663): BIOmarker based diagnostic TOOLkit to personalize pharmacological approaches in congestive heart failure |
| 01/05/2023 |
EU funding (€9,875,071): Preventing lifetime obesity by early risk-factor identification, prognosis and intervention |
| 01/10/2023 |
EU funding (€9,942,459): INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE |
| 14/11/2023 |
EU funding (€9,958,833): PROGNOSIS IMPROVEMENT OF UNPROVOKED VENOUS THROMBOEMBOLISM USING PERSONALIZED ANTICOAGULANT THERAPY |
| 01/01/2023 |
EU funding (€91.6M): European Partnership on Transforming Health and Care Systems |
| 01/09/2023 |
EU funding (€937,150): Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging |
